Intelligent Pills Market Expansion Continues, with Forecast Valuation of $7.66 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Intelligent Pills Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Growth in the smart pill market has accelerated in recent years. It's projected to expand from a worth of $4.11 billion in 2024 to $4.66 billion in 2025. The predicted compound annual growth rate (CAGR) stands at 13.5%. Historical period growth can be traced back to the rising demand for individualized medical treatments, enhanced preference for intelligent healthcare devices, an increase in cases of chronic illnesses, heightened investments in digital healthcare technologies, and an escalating necessity for monitoring patients from a distance.

Intelligent Pills Market Size Forecast: What's the Projected Valuation by 2029?
There is an expectation for a substantial expansion in the size of the intelligent pills market over the upcoming years. It's projected to soar to $7.66 billion in 2029 with a compound annual growth rate of 13.2%. Various elements are driving this forecast period's growth, such as the increased demand for instantaneous health-related data, a higher level of acceptance for internet-connected medical devices, a rise in health-aware consumers, the enhanced management of healthcare data, and the on-going adoption of telemedicine. Key trends anticipated during the forecast period involve the creation of artificial intelligence-aided pills, the development of self-regulating pills, the synergy with mobile health applications, alignment with wearable technology, and advancements in bio-sensing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/intelligent-pills-global-market-report

What Are the Drivers Transforming the Intelligent Pills Market?
The intelligent pills market is predicted to expand due to the increasing prevalence of lifestyle-related disorders. These are non-transmittable diseases predominantly caused or impacted by individual's daily habits, actions, and decisions. The surge in lifestyle-related disorders can be mainly attributed to unhealthy eating habits leading to conditions like obesity, heart diseases, diabetes, and other chronic diseases. Intelligent pills offer a personalized treatment for these disorders by giving real-time health monitoring and data-informed insights, enhancing adherence to medication, and maximizing therapeutic effects. For example, the Centers for Disease Control and Prevention, a government agency based in the US, recorded that in 2022, the adult obesity rate was 35% or higher in 22 states, which is an increase from 19 states in 2021. Hence, the increase in lifestyle-related disorders fuels the growth of the intelligent pills market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24573&type=smp

What Long-Term Trends Will Define the Future of the Intelligent Pills Market?
Prominent organizations in the intelligent pills market are concentrating on the development of cutting-edge technology solutions resembling digital health products, in order to augment patient monitoring and boost medication compliance. These digital health products are essentially tech-based tools and platforms such as health applications on mobile devices, wearable devices, intelligent pills, and telemedicine systems which facilitate monitoring, managing, and enhancing health results, often in real-time. For example, HealthBeacon plc, a therapeutics company based in Ireland, unveiled the HB Smart Pills Management System in September 2022 to improve the management of medication for patients dealing with complex pill regimes. This system provides features like reminders for medication, alerts for refill, visual images of pill containers to ensure compliance, and delivers actionable feedback to both patients and healthcare professionals for superior management of medication. This system has been specifically crafted to aid patients with intricate medication schedules, thereby decreasing occurrences of missed doses and escalating overall treatment results.

Which Segments in the Intelligent Pills Market Offer the Most Profit Potential?
The intelligent pills market covered in this report is segmented -

1) By Type: Occult GI Bleeding, Chron's Disease, Small Bowel Tumors, Celiac Disease, Inherited Polyposis Syndromes, Neurological Disorder
2) By Target Area: Esophagus, Stomach, Small Intestine, Large Intestine
3) By Application: Capsule Endoscopy, Drug Delivery, Patient Monitoring
4) By End-User: Hospital Pharmacy, Clinics, Research Institutes, Home Healthcare

Subsegments
1) By Occult GI Bleeding: Detection Of Hidden Gastrointestinal Bleeding, Non-Invasive Diagnosis Of Occult Blood Loss
2) By Crohn's Disease: Monitoring Disease Progression, Assessment Of Intestinal Inflammation
3) By Small Bowel Tumors: Tumor Identification In The Small Intestine, Tumor Monitoring And Diagnosis
4) By Celiac Disease: Detection Of Gluten-Induced Damage In The Intestine, Monitoring Adherence To Gluten-Free Diet
5) By Inherited Polyposis Syndromes: Detection Of Polyps In The Gastrointestinal Tract, Risk Assessment And Monitoring For Genetic Polyposis
6) By Neurological Disorders: Monitoring Gut-Brain Interactions, Diagnosis Of Gastrointestinal Symptoms In Neurological Diseases

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24573&type=smp

Which Firms Dominate the Intelligent Pills Market by Market Share and Revenue in 2025?
Major companies operating in the intelligent pills market are Medtronic plc, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Otsuka Pharmaceutical Co. Ltd., Lonza Group AG, Olympus Corporation, Lloyds Pharmacy Limited, STRATACACHE Inc., Check-Cap Ltd., Proteus Digital Health Inc., CapsoVision Inc., Medisafe Inc., IntroMedic Co. Ltd., Jinshan Science And Technology (Group) Co. Ltd., Innurvation Inc., AARDEX Group SA, BodyCap SAS, AnX Robotica Corp., EtectRx Inc., Given Imaging Ltd.

Which Regions Offer the Highest Growth Potential in the Intelligent Pills Market?
North America was the largest region in the intelligent pills market in 2024. The regions covered in the intelligent pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24573

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.